...
首页> 外文期刊>Obstetrics and Gynecology: Journal of the American College of Obstetricians and Gynecologists >Night sweats and elevated follicle-stimulating hormone levels while taking selective serotonin reuptake inhibitors.
【24h】

Night sweats and elevated follicle-stimulating hormone levels while taking selective serotonin reuptake inhibitors.

机译:盗汗和促卵泡激素水平升高,同时服用选择性5-羟色胺再摄取抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to women with depression and anxiety disorders. Although night sweats are a reported adverse effect, some women have relief of vasomotor symptoms during perimenopausal period while taking them. The relationships between SSRIs, thermoregulation, gonadotropins, and estrogen and their connection to fertility remain unclear. CASE: A reproductive-aged woman, seeking treatment for infertility, experienced night sweats and elevated follicle-stimulating hormone levels while taking SSRIs for treatment of depression. CONCLUSION: Many women of reproductive age are taking SSRIs, but the affect of SSRIs on normal reproductive function is unknown and further research in this area is needed.
机译:背景:选择性5-羟色胺再摄取抑制剂(SSRIs)通常用于抑郁症和焦虑症妇女。尽管据报道盗汗是一种不良影响,但某些妇女在服用绝经期后可以缓解血管舒缩症状。 SSRI,温度调节,促性腺激素和雌激素之间的关系以及它们与生育力的关系仍不清楚。案例:一位正在接受不育治疗的育龄妇女,在服用SSRI治疗抑郁症时经历了盗汗和促卵泡激素水平升高。结论:许多育龄妇女正在服用SSRIs,但是SSRIs对正常生殖功能的影响尚不清楚,因此需要在这一领域进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号